Gimeracil is a drug that is known as a dihydropyrimidine dehydrogenase inhibitor. It inhibits 5-FU degradation more effectively than uracil in laboratory studies. Gimeracil when given with another drug called tegafur can markedly increase the anticancer activity of tegafur.